Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CAVALIERE F, Cerf L, Dehay B, Ramos-Gonzalez P, et al
    In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
    Neurobiol Dis. 2017;103:101-112.
    PubMed     Text format     Abstract available


  2. ROCHA EM, De Miranda B, Sanders LH
    Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Neurobiol Dis. 2017 Apr 8. pii: S0969-9961(17)30080.
    PubMed     Text format     Abstract available


    March 2017
  3. LALOUX C, Gouel F, Lachaud C, Timmerman K, et al
    Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
    Neurobiol Dis. 2017 Mar 28. pii: S0969-9961(17)30061.
    PubMed     Text format     Abstract available


    December 2016
  4. SONG L, McMackin M, Nguyen A, Cortopassi G, et al
    Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30314.
    PubMed     Text format     Abstract available


  5. MASILAMONI GJ, Groover O, Smith Y
    Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30315.
    PubMed     Text format     Abstract available


  6. VAINE CA, Shin D, Liu C, Hendriks W, et al
    X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Neurobiol Dis. 2016 Dec 22. pii: S0969-9961(16)30299.
    PubMed     Text format     Abstract available


  7. GENG X, Zhang J, Jiang Y, Ashkan K, et al
    Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Neurobiol Dis. 2016;98:100-107.
    PubMed     Text format     Abstract available


  8. KOZINA EA, Kim AR, Kurina AY, Ugrumov MV, et al
    Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Neurobiol Dis. 2016;98:108-121.
    PubMed     Text format     Abstract available


    September 2016
  9. NKILIZA A, Mutez E, Simonin C, Lepretre F, et al
    RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Neurobiol Dis. 2016 Sep 20. pii: S0969-9961(16)30230.
    PubMed     Text format     Abstract available


  10. KIRIK D, Cederfjall E, Halliday G, Petersen A, et al
    Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
    Neurobiol Dis. 2016 Sep 8. pii: S0969-9961(16)30222.
    PubMed     Text format     Abstract available


    August 2016
  11. TRAGER MH, Koop MM, Velisar A, Blumenfeld Z, et al
    Subthalamic Beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Neurobiol Dis. 2016 Aug 20. pii: S0969-9961(16)30201.
    PubMed     Text format     Abstract available


    July 2016
  12. RUNEBERG-ROOS P, Piccinini E, Penttinen AM, Matlik K, et al
    Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.
    Neurobiol Dis. 2016 Jul 14. pii: S0969-9961(16)30167.
    PubMed     Text format     Abstract available


  13. PETRYSZYN S, Di Paolo T, Parent A, Parent M, et al
    The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys.
    Neurobiol Dis. 2016 Jul 4. pii: S0969-9961(16)30159.
    PubMed     Text format     Abstract available


    June 2016
  14. PADEL T, Ozen I, Boix J, Barbariga M, et al
    Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease.
    Neurobiol Dis. 2016 Jun 7. pii: S0969-9961(16)30135.
    PubMed     Text format     Abstract available


    May 2016
  15. PODLESNIY P, Vilas D, Taylor P, Shaw LM, et al
    Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.
    Neurobiol Dis. 2016;94:10-17.
    PubMed     Text format     Abstract available


  16. DO VAN B, Gouel F, Jonneaux A, Timmerman K, et al
    Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.
    Neurobiol Dis. 2016 May 14. pii: S0969-9961(16)30105.
    PubMed     Text format     Abstract available


  17. SIDDIQUI A, Rane A, Rajagopalan S, Chinta SJ, et al
    Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Neurobiol Dis. 2016 May 13. pii: S0969-9961(16)30103.
    PubMed     Text format     Abstract available


  18. GORDON R, Singh N, Lawana V, Ghosh A, et al
    Protein kinase Cdelta upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Neurobiol Dis. 2016 May 2. pii: S0969-9961(16)30090.
    PubMed     Text format     Abstract available


    April 2016
  19. MATZNER A, Moran A, Erez Y, Tischler H, et al
    Beta oscillations in the parkinsonian primate: Similar oscillations across different populations.
    Neurobiol Dis. 2016 Apr 12. pii: S0969-9961(16)30076.
    PubMed     Text format     Abstract available


    March 2016
  20. PEREZ-ORTEGA J, Duhne M, Lara-Gonzalez E, Plata V, et al
    Pathophysiological signatures of functional connectomics in parkinsonian and dyskinetic striatal microcircuits.
    Neurobiol Dis. 2016 Mar 4. pii: S0969-9961(16)30043.
    PubMed     Text format     Abstract available


    February 2016
  21. SANTORO M, Maetzler W, Stathakos P, Martin HL, et al
    In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
    Neurobiol Dis. 2016 Feb 24. pii: S0969-9961(16)30040.
    PubMed     Text format     Abstract available


  22. WANG DD, de Hemptinne C, Miocinovic S, Qasim SE, et al
    Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Neurobiol Dis. 2016 Feb 13. pii: S0969-9961(16)30036.
    PubMed     Text format     Abstract available


  23. PARK HY, Ryu YK, Kim YH, Park TS, et al
    Gadd45beta ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model.
    Neurobiol Dis. 2016 Feb 10. pii: S0969-9961(16)30034.
    PubMed     Text format     Abstract available


    January 2016
  24. ARCURI L, Viaro R, Bido S, Longo F, et al
    Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
    Neurobiol Dis. 2016 Jan 21. pii: S0969-9961(16)30016.
    PubMed     Text format     Abstract available


    December 2015
  25. MACHADO V, Haas SJ, von Bohlen Und Halbach O, Wree A, et al
    Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson s disease.
    Neurobiol Dis. 2015 Dec 27. pii: S0969-9961(15)30118.
    PubMed     Text format     Abstract available


    November 2015
  26. QASIM SE, de Hemptinne C, Swann NC, Miocinovic S, et al
    Electrocorticography reveals beta desynchronization in the basal ganglia-cortical loop during rest tremor in Parkinson's disease.
    Neurobiol Dis. 2015 Nov 27. pii: S0969-9961(15)30101.
    PubMed     Text format     Abstract available


  27. DUPRE KB, Cruz AV, McCoy AJ, Delaville C, et al
    Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Neurobiol Dis. 2015 Nov 13. pii: S0969-9961(15)30088.
    PubMed     Text format     Abstract available


  28. VON STOCKUM S, Nardin A, Schrepfer E, Ziviani E, et al
    Mitochondrial dynamics and mitophagy in Parkinson's disease: A fly point of view.
    Neurobiol Dis. 2015 Nov 6. pii: S0969-9961(15)30081.
    PubMed     Text format     Abstract available


    October 2015
  29. KOHL Z, Abdallah NB, Vogelgsang J, Tischer L, et al
    Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC alpha-synuclein transgenic rat model of Parkinson's disease.
    Neurobiol Dis. 2015 Oct 30. pii: S0969-9961(15)30079.
    PubMed     Text format     Abstract available


  30. DUVAL C, Daneault JF, Hutchison WD, Sadikot AF, et al
    A brain network model explaining tremor in Parkinson's disease.
    Neurobiol Dis. 2015 Oct 9. pii: S0969-9961(15)30065.
    PubMed     Text format     Abstract available


    August 2015
  31. CENCI MA, Francardo V, O'Sullivan SS, Lindgren HS, et al
    Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
    Neurobiol Dis. 2015 Aug 29. pii: S0969-9961(15)30046.
    PubMed     Text format     Abstract available


    July 2015
  32. STAVARACHE MA, Musatov S, McGill M, Vernov M, et al
    The Tumor Suppressor PTEN Regulates Motor Responses to Striatal Dopamine in Normal and Parkinsonian Animals.
    Neurobiol Dis. 2015 Jul 29. pii: S0969-9961(15)30017.
    PubMed     Text format     Abstract available


  33. CISBANI G, Drouin-Ouellet J, Gibrat C, Saint-Pierre M, et al
    Cystamine/cysteamine rescue the dopaminergic system and show neurorestorative properties in an animal model of Parkinson's disease.
    Neurobiol Dis. 2015 Jul 29. pii: S0969-9961(15)30015.
    PubMed     Text format     Abstract available


  34. TAGLIAFERRO P, Kareva T, Oo TF, Yarygina O, et al
    An Early Axonopathy in a hLRRK2(R1441G) Transgenic Model of Parkinson Disease.
    Neurobiol Dis. 2015 Jul 17. pii: S0969-9961(15)30013.
    PubMed     Text format     Abstract available


  35. VAIKATH NN, Majbour NK, Paleologou KE, Ardah MT, et al
    Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology.
    Neurobiol Dis. 2015;79:81-99.
    PubMed     Text format     Abstract available


    June 2015
  36. JENNINGS KA, Platt NJ, Cragg SJ
    The impact of a parkinsonian lesion on dynamic striatal dopamine transmission depends on nicotinic receptor activation.
    Neurobiol Dis. 2015 Jun 25. pii: S0969-9961(15)00233.
    PubMed     Text format     Abstract available


  37. TONG J, Ang LC, Williams B, Furukawa Y, et al
    Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to alpha-Synuclein Accumulation.
    Neurobiol Dis. 2015 Jun 20. pii: S0969-9961(15)00228.
    PubMed     Text format     Abstract available


  38. WU T, Hallett M, Chan P
    Motor Automaticity in Parkinson's Disease.
    Neurobiol Dis. 2015 Jun 20. pii: S0969-9961(15)00232.
    PubMed     Text format     Abstract available


  39. AMBROSI G, Ghezzi C, Zangaglia R, Levandis G, et al
    Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
    Neurobiol Dis. 2015 Jun 18. pii: S0969-9961(15)00226.
    PubMed     Text format     Abstract available


  40. FREMONT R, Tewari A, Khodakhah K
    Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism.
    Neurobiol Dis. 2015 Jun 17. pii: S0969-9961(15)00222.
    PubMed     Text format     Abstract available


  41. COTE M, Bourque M, Poirier AA, Aube B, et al
    GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of parkinson's disease.
    Neurobiol Dis. 2015 Jun 4. pii: S0969-9961(15)00191.
    PubMed     Text format     Abstract available


    May 2015
  42. COLLIER TJ, O'Malley J, Rademacher DJ, Stancati JA, et al
    Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
    Neurobiol Dis. 2015;77:191-203.
    PubMed     Text format     Abstract available


    April 2015
  43. SLONE SR, Lavalley N, McFerrin M, Wang B, et al
    Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.
    Neurobiol Dis. 2015 Apr 8. pii: S0969-9961(15)00108.
    PubMed     Text format     Abstract available


  44. LIM SA, Xia R, Ding Y, Won L, et al
    Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
    Neurobiol Dis. 2015;76:67-76.
    PubMed     Text format     Abstract available


    March 2015
  45. LEI P, Ayton S, Appukuttan AT, Volitakis I, et al
    Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse.
    Neurobiol Dis. 2015 Mar 18. pii: S0969-9961(15)00087.
    PubMed     Text format     Abstract available


  46. BARROSO-CHINEA P, Thiolat ML, Bido S, Martinez A, et al
    D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly.
    Neurobiol Dis. 2015 Mar 9. pii: S0969-9961(15)00059.
    PubMed     Text format     Abstract available


  47. WANG Z, Guo Y, Myers KG, Heintz R, et al
    Recruitment of the prefrontal cortex and cerebellum in Parkinsonian rats following skilled aerobic exercise.
    Neurobiol Dis. 2015 Mar 3. pii: S0969-9961(15)00054.
    PubMed     Text format     Abstract available


    February 2015
  48. TSIKA E, Nguyen AP, Dusonchet J, Colin P, et al
    Adenoviral-Mediated Expression of G2019S LRRK2 Induces Striatal Pathology in a Kinase-Dependent Manner in a Rat Model of Parkinson's Disease.
    Neurobiol Dis. 2015 Feb 27. pii: S0969-9961(15)00053.
    PubMed     Text format     Abstract available


  49. CREDLE JJ, Forcelli PA, Delannoy M, Oaks AW, et al
    alpha-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.
    Neurobiol Dis. 2015 Feb 26. pii: S0969-9961(15)00025.
    PubMed     Text format     Abstract available


  50. MOLINET-DRONDA F, Gago B, Quiroga-Varela A, Juri C, et al
    Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study.
    Neurobiol Dis. 2015 Feb 12. pii: S0969-9961(15)00019.
    PubMed     Text format     Abstract available


    January 2015
  51. LOBB CJ, Jaeger D
    Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states.
    Neurobiol Dis. 2015 Jan 6. pii: S0969-9961(14)00397.
    PubMed     Text format     Abstract available


  52. SOLIS O, Espadas I, Del-Bel EA, Moratalla R, et al
    Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
    Neurobiol Dis. 2015;73:49-59.
    PubMed     Text format     Abstract available


    December 2014
  53. PIENAAR IS, Lee CH, Elson JL, McGuinness L, et al
    Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.
    Neurobiol Dis. 2014 Dec 19. pii: S0969-9961(14)00377.
    PubMed     Text format     Abstract available


    November 2014
  54. GLAAB E, Schneider R
    Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease.
    Neurobiol Dis. 2014;74C:1-13.
    PubMed     Text format     Abstract available


    October 2014
  55. BORTOLANZA M, Cavalcanti-Kiwiatkoski R, Padovan-Neto FE, da-Silva CA, et al
    Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
    Neurobiol Dis. 2014;73C:377-387.
    PubMed     Text format     Abstract available


  56. DANIEL G, Musso A, Tsika E, Fiser A, et al
    alpha-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Neurobiol Dis. 2014;73C:229-243.
    PubMed     Text format     Abstract available


  57. ZARBIV Y, Simhi-Haham D, Israeli E, Elhadi SA, et al
    Lysine residues at the first and second KTKEGV repeats mediate alpha-Synuclein binding to membrane phospholipids.
    Neurobiol Dis. 2014;70:90-8.
    PubMed     Text format     Abstract available


    September 2014
  58. KOVACS GG, Breydo L, Green R, Kis V, et al
    Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread.
    Neurobiol Dis. 2014;69:76-92.
    PubMed     Text format     Abstract available


    August 2014
  59. CHOU JS, Chen CY, Chen YL, Weng YH, et al
    (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
    Neurobiol Dis. 2014;68:190-9.
    PubMed     Text format     Abstract available


    July 2014
  60. FERNAGUT PO, Dehay B, Maillard A, Bezard E, et al
    Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.
    Neurobiol Dis. 2014;67:133-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: